Uncategorized

Rybrevant Faspro is a new under-the-skin (subcutaneous, or SC) injection form of the anticancer medicine Rybrevant (amivantamab). The FDA has now approved it in combination with another medicine called Lazcluze (lazertinib) as a first-line treatment for… Read more

Rybrevant Faspro is an under-the-skin (subcutaneous, or SC) injection form of the anticancer medicine Rybrevant (amivantamab). The FDA has approved a new monthly dosing option for Rybrevant Faspro to be used in combination with the oral… Read more

Yuvezzi is a new prescription eye drop approved to treat presbyopia, a common condition that makes it harder to see things up close as you age. It’s the only FDA-approved eye drop that combines two… Read more

Fasenra (benralizumab), a targeted medicine called a monoclonal antibody, binds to and reduces levels of eosinophils, a type of immune cell that can cause inflammation.This can ease symptoms in people with eosinophil-driven conditions.First approved in… Read more

Cablivi (caplacizumab) is an injectable medicine used to treat a rare and serious blood condition called acquired thrombotic thrombocytopenic purpura (aTTP). The FDA has approved Cablivi to be used along with plasma exchange and immunosuppressive… Read more

Trimbow (beclomethasone dipropionate/formoterol fumarate/glycopyrrolate), a single inhaler that contains three medicines, is now FDA-approved for maintaining asthma control in adults. About 27 million Americans have asthma, of which 30% to 50% have frequent symptoms that… Read more

Datroway (datopotamab deruxtecan-dlnk) is a prescription intravenous targeted cancer medicine called an antibody-drug conjugate (ADC).The FDA has approved it for adults with triple-negative breast cancer (TNBC) when the tumor cannot be removed with surgery (unresectable)… Read more

Linzess (linaclotide) is a prescription once-daily oral medicine used to treat certain types of constipation, including those with no known cause and those related to irritable bowel syndrome (IBS-C). In the current approval, the FDA… Read more

Imfinzi (durvalumab) is a prescription immunotherapy medicine used to treat different types of cancer. The FDA has approved the combination of Imfinzi and Bacillus Calmette-Guérin (BCG) therapy to treat a high-risk, early form of bladder… Read more

Tecentriq (atezolizumab) and Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs) are prescription immunotherapy medicines used to help the body’s immune system fight cancer. The FDA has now approved them to treat muscle-invasive bladder cancer (MIBC) in adults after… Read more